Skip to content
OpenCapital
Get started

Fulcrum Therapeutics, Inc. FULC Q4 2025 Annual earnings

Reported February 24, 2026 · Before market open

EPS-$0.31In line
EPS estimate-$0.31

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.21

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.06
Q4 2025-$0.31In line
Q3 2025-$0.31Miss by $0.02Q2 2025-$0.28Beat by $0.01Q1 2025-$0.28Beat by $0.01Q4 2024-$0.31Miss by $0.03

Ask the moment Fulcrum Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fulcrum Therapeutics, Inc. report Q4 2025 earnings?
Fulcrum Therapeutics, Inc. (FULC) reported Q4 2025 earnings on February 24, 2026 before market open.
What were Fulcrum Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Fulcrum Therapeutics, Inc. reported eps of $-0.31 for Q4 2025.
Did Fulcrum Therapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.31 by $0.00.
How did Fulcrum Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.31.
Where can I find Fulcrum Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-065190) and the 10-K periodic report (0001193125-26-065197) directly on SEC EDGAR. The filing index links above go to sec.gov.